Casdin Capital 13F holdings, Q3 2021
Holdings as of September 30, 2021 · filings on SEC EDGAR · latest filing →
Casdin Capital disclosed 53 US equity positions worth $4.0bn in its Q3 2021 13F filing. The largest position was INVITAE CORP at 8.7% of the reported book, followed by BLFS and EXK. Against the Q2 2021 filing, it opened 7 new positions, added to 9 and reduced 3 among the top 50 holdings.
What did Casdin Capital own in Q3 2021? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2021 |
|---|---|---|---|---|---|---|---|
| 1 | INVITAE CORP | 8.7% | $346.9m | 12,203,669 | 0% | held | |
| 2 | BLFS BIOLIFE SOLUTIONS INC | Healthcare | 8.0% | $320.2m | 7,566,292 | 2% | added |
| 3 | EXK EXACT SCIENCES CORP | Basic Materials | 5.6% | $225.3m | 2,360,186 | 0% | held |
| 4 | PACB PACIFIC BIOSCIENCES CALIF IN | Healthcare | 5.1% | $204.2m | 7,990,652 | 60% | added |
| 5 | FATE FATE THERAPEUTICS INC | Healthcare | 5.0% | $201.5m | 3,400,000 | 0% | held |
| 6 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 4.7% | $188.8m | 1,000,000 | 0% | held |
| 7 | MXCT MAXCYTE INC | 4.3% | $170.6m | 13,971,334 | – | new | |
| 8 | 2655787D BLUEPRINT MEDICINES CORP | 4.0% | $159.4m | 1,550,000 | 0% | held | |
| 9 | SOMALOGIC INC | 3.8% | $153.5m | 12,389,082 | – | new | |
| 10 | VERVE THERAPEUTICS INC | 3.6% | $142.8m | 3,038,167 | 0% | held | |
| 11 | RLAY RELAY THERAPEUTICS INC | Healthcare | 2.9% | $115.7m | 3,668,574 | 9% | added |
| 12 | TWST TWIST BIOSCIENCE CORP | Healthcare | 2.7% | $107.0m | 1,000,000 | 0% | held |
| 13 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 2.5% | $101.7m | 1,100,000 | 24% | added |
| 14 | CDXS CODEXIS INC | Healthcare | 2.5% | $100.7m | 4,330,000 | 0% | held |
| 15 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 2.5% | $99.9m | 2,165,000 | 0% | held |
| 16 | ABSI ABSCI CORPORATION | 2.2% | $89.8m | 7,718,593 | – | new | |
| 17 | DNLI DENALI THERAPEUTICS INC | Healthcare | 2.1% | $85.8m | 1,700,000 | 6% | added |
| 18 | GINKGO BIOWORKS HOLDINGS INC | 2.1% | $83.5m | 7,202,808 | – | new | |
| 19 | IPSC CENTURY THERAPEUTICS INC | Healthcare | 2.0% | $80.7m | 3,206,380 | 0% | held |
| 20 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.9% | $77.0m | 2,800,000 | 21% | added |
| 21 | CDNA CAREDX INC | Healthcare | 1.9% | $75.6m | 1,193,335 | 0% | held |
| 22 | TNYA TENAYA THERAPEUTICS INC | 1.8% | $74.1m | 3,586,818 | – | new | |
| 23 | BEAM BEAM THERAPEUTICS INC | Healthcare | 1.8% | $71.2m | 818,820 | 0% | held |
| 24 | TNGX TANGO THERAPEUTICS INC | Healthcare | 1.8% | $71.0m | 5,487,910 | – | new |
| 25 | DERMTECH INC | 1.4% | $56.0m | 1,745,000 | 0% | held | |
| 26 | ONC BEIGENE LTD | Healthcare | 1.4% | $54.5m | 150,000 | 0% | held |
| 27 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 1.3% | $54.0m | 2,100,000 | 71% | added |
| 28 | GLOBAL BLOOD THERAPEUTICS IN | 1.2% | $49.0m | 1,925,000 | 47% | added | |
| 29 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 1.2% | $48.9m | 1,440,000 | 0% | held |
| 30 | WGS SEMA4 HOLDINGS CORP | 0.9% | $38.0m | 5,000,000 | – | new | |
| 31 | ALEC ALECTOR INC | Healthcare | 0.9% | $37.7m | 1,650,000 | 0% | held |
| 32 | GENERATION BIO CO | 0.8% | $33.2m | 1,324,275 | -18% | reduced | |
| 33 | SINGULAR GENOMICS SYSTEMS IN | 0.8% | $30.1m | 2,692,870 | 0% | held | |
| 34 | 4D MOLECULAR THERAPEUTICS IN | 0.8% | $30.1m | 1,115,455 | -0% | held | |
| 35 | CRSP CRISPR THERAPEUTICS AG | Healthcare | 0.7% | $29.8m | 266,430 | 0% | held |
| 36 | MAGENTA THERAPEUTICS INC | 0.7% | $28.4m | 3,901,589 | 17% | added | |
| 37 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 0.6% | $22.9m | 1,200,000 | 0% | held |
| 38 | GLUE MONTE ROSA THERAPEUTICS INC | 0.5% | $21.4m | 960,883 | 0% | held | |
| 39 | ZLAB ZAI LAB LTD | Healthcare | 0.5% | $20.0m | 190,000 | 0% | held |
| 40 | 23ANDME HOLDING CO | 0.4% | $16.7m | 1,841,457 | -33% | reduced | |
| 41 | MASS 908 DEVICES INC | 0.3% | $13.2m | 406,502 | 0% | held | |
| 42 | RXRX RECURSION PHARMACEUTICALS IN | Healthcare | 0.3% | $12.6m | 548,156 | 0% | held |
| 43 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 0.3% | $12.6m | 601,515 | 0% | held |
| 44 | KRONOS BIO INC | 0.3% | $12.2m | 583,436 | 0% | held | |
| 45 | DECIBEL THERAPEUTICS INC | 0.2% | $9.0m | 1,170,048 | -0% | held | |
| 46 | TKNO ALPHA TEKNOVA INC | 0.2% | $7.5m | 300,000 | 0% | held | |
| 47 | ORCHARD THERAPEUTICS PLC | 0.1% | $5.9m | 2,575,000 | -20% | reduced | |
| 48 | SEER SEER INC | 0.1% | $5.2m | 150,000 | 0% | held | |
| 49 | BERKELEY LTS INC | 0.1% | $3.9m | 200,000 | 0% | held | |
| 50 | STOK STOKE THERAPEUTICS INC | Healthcare | 0.1% | $3.1m | 120,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.